![Eric-Paul Pâques](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric-Paul Pâques
Voorzitter bij Proteros biostructures GmbH
Actieve functies van Eric-Paul Pâques
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Proteros biostructures GmbH
![]() Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Voorzitter | - | - |
Directeur/Bestuurslid | - | - | |
RWTH Aachen University | Corporate Officer/Principal | - | - |
Syneos Health NC LLC
![]() Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Syneos Health LLC operates therapeutically focused global contract research organization. It provides pharma and biotech services. The firm specializes in the hematology, immunology and inflammation infectious diseases, oncology, ophthalmology, cardiovascular, CNS analgesia, CNS neurology, CNS psychiatry, endocrinology, and gastroenterology and hepatology. The company was founded by Kenneth A. Selzer in 1985 and is headquartered in Raleigh, NC. | Directeur/Bestuurslid | 01-02-2017 | - |
Independent Dir/Board Member | 01-02-2017 | - | |
Novadip Biosciences SA
![]() Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Voorzitter | 30-05-2017 | - |
Grunenthal Italia Srl
![]() Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | Directeur/Bestuurslid | - | - |
Loopbaan van Eric-Paul Pâques
Eerdere bekende functies van Eric-Paul Pâques
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Grünenthal GmbH
![]() Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Algemeen Directeur | 30-05-2013 | 01-10-2016 |
Hoofd Techniek/Wetenschap/O&O | 01-01-1994 | 29-06-2010 | |
Corporate Officer/Principal | 29-06-2010 | 31-05-2013 | |
Behringwerke AG
![]() Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Hoofd Techniek/Wetenschap/O&O | 01-01-1993 | 01-01-1993 |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | Directeur/Bestuurslid | 08-02-2017 | - |
Independent Dir/Board Member | 08-02-2017 | - | |
LABORATORIOS ANDROMACO S.A. | Directeur/Bestuurslid | 15-01-2014 | - |
Opleiding van Eric-Paul Pâques
Ludwig-Maximilians-Universität München | Undergraduate Degree |
Statistieken
Internationaal
Duitsland | 6 |
Verenigde Staten | 3 |
Chili | 2 |
Operationeel
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 8 |
---|---|
Grünenthal GmbH
![]() Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
Behringwerke AG
![]() Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Health Technology |
Laboratorios Andrómaco SA
![]() Laboratorios Andrómaco SA Pharmaceuticals: MajorHealth Technology Laboratorios Andrómaco SA is a pharmaceutical company. It is engaged in the production and marketing of pharmaceutical products and diagnostics. The company was founded in 1942 and is headquartered in Peñalolén, Chile. | Health Technology |
Proteros biostructures GmbH
![]() Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Health Services |
INC Research Holdings, Inc.
![]() INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | Commercial Services |
Syneos Health NC LLC
![]() Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Syneos Health LLC operates therapeutically focused global contract research organization. It provides pharma and biotech services. The firm specializes in the hematology, immunology and inflammation infectious diseases, oncology, ophthalmology, cardiovascular, CNS analgesia, CNS neurology, CNS psychiatry, endocrinology, and gastroenterology and hepatology. The company was founded by Kenneth A. Selzer in 1985 and is headquartered in Raleigh, NC. | Commercial Services |
Novadip Biosciences SA
![]() Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
Grunenthal Italia Srl
![]() Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | Health Technology |
- Beurs
- Insiders
- Eric-Paul Pâques
- Ervaring